Skip to main content
Erschienen in: World Journal of Surgical Oncology 1/2009

Open Access 01.12.2009 | Research

Nine years experience in surgical approach of leiomyomatosis of esophagus

verfasst von: Christos Asteriou, Dimitrios Konstantinou, Miltiadis Lalountas, Athanassios Kleontas, Konstantinos Setzis, Georgios Zafiriou, Nikolaos Barbetakis

Erschienen in: World Journal of Surgical Oncology | Ausgabe 1/2009

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Abstract

Background

Leiomyomas of esophagus, although rare, are the most frequent benign tumors of esophagus. Aim of this study is the presentation of 7 patients with esophageal leiomyomas who underwent surgical treatment during a 9-year period.

Methods

Epidemiological data (sex, age), the presenting symptoms, diagnostic examinations, tumor location, histopathological findings and the safety and efficacy of surgical resection are analyzed and assessed.

Results

5 men and 2 women with mean age of 56.9 years were operated. In 3 cases the tumor was located at the lower esophagus, while in the other 4 cases, the leiomyoma was found at the median third of esophagus. 4 patients had severe symptoms related to the leiomyoma, such as dysphagia and epigastric pain. All patients underwent a right postolateral thoracotomy with enucleation of the lesion. None of them received resection of part of the esophagus. The mean diameter of the resected tumors was 4.3 cm. The dimensions of leiomyomas were immediately associated with the symptoms. In no case was detected malignancy or recurrence. All patients were relieved from their symptoms, while postoperative morbidity and mortality did not occur.

Conclusions

Esophageal leiomyoma is a benign tumor, which causes symptoms only if its size becomes large. Surgical enucleation is considered to be safe and effective, without complications.
Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​1477-7819-7-102) contains supplementary material, which is available to authorized users.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

CA, DK, ML, AK, KS, and GZ took part in the care of the patients and contributed equally in carrying out the medical literature search and preparation of the manuscript. NB participated in the care of the patients and had the supervision of this report. All authors approved the final manuscript.

Background

The esophageal leiomyoma is a benign tumor of the esophagus. Other non-malignant lesions of esophagus are hemangioma, lymphangioma, squamous papilloma, fibrovascular polyp and granular cell myoblastoma. The incidence of this kind of lesions is referred to be almost 1% of the esophageal neoplasms in the international literature [1]. Leiomyomas are the most common benign tumors of esophagus. The main symptoms usually are dysphagia and epigastric pain, but they are not specific for the disease. Differential diagnosis should always include esophageal cancer [2]. It is important for the modern cardiothoracic surgeon to be aware of this entity. Here, a small case series of 7 patients who were treated in our Institute during the last 9 years is presented, with emphasis in diagnosis and management.

Patients and Methods

This study is a retrospective analysis of the medical records of patients, whose diagnosis was a possible esophageal leiomyoma. The study took place at the Theagenio Cancer Hospital of Thessaloniki from September 2000 to September 2009. Seven patients were detected. The epidemiological data (sex, age), presenting symptoms, diagnostic examinations, tumor location, histopathological findings and the safety and efficacy of the surgical resection were analyzed. The standard examinations included preoperative esophagogastroscopy, endoscopic ultrasonography and computed tomography of the chest. Fine needle aspiration was not performed in any case.

Results

Patients' group was consisted of five males and two females. Their age ranged from 48 to 67 years (mean age: 56.9 years). The most common symptoms were dysphagia and epigastric pain, which were present in four cases. In addition, one patient was complaining for retrosternal burnings. The rest of the cases had limited symptomatology, like unspecified discomfort located at the chest or the upper abdomen. All patients were subjected to the standard examinations, which demonstrated an esophageal tumor with features compatible with leiomyoma. In three cases the tumor was located at the lower third of the esophagus, while four lesions were detected at the median third. In all cases a right postolateral thoracotomy carried out and myotomy of esophagus with enucleation of the neoplasm took place. Frozen sections showed typical leiomyoma of esophagus. None of the patients underwent resection of part of the organ. The mean diameter of the resected tumors was 4.3 cm. Malignancy or recurrence was not detected. The mean in-hospital staying was 7 days. Complications did not occur. All patients were relieved from their symptoms, after surgical removal of the tumor. Postoperative follow-up did not reveal any morbidity or mortality related to the primary diagnosis. Clinical presentation, diagnostic findings and management of the patients are summarized in table 1.
Table 1
Clinical presentation, diagnostic examinations' results and surgical approach.
Sex
Age
Symptoms
EGS-EUS
Diameter
Treatment
67
Dysphagia
Submucosal hypoechoic tumor at 22-28 cm
5,9 cm
Right Thoracotomy-Enucleation
48
Epigastric discomfort
Submucosal hypoechoic nodule at 29-32 cm
2 cm
Right Thoracotomy-Enucleation
51
Epigastric pain, Dysphagia
Submucosal hypoechoic tumor at 23-28 cm
4,8 cm
Right Thoracotomy-Enucleation
59
Epigastric discomfort
Submucosal hypoechoic nodule at 22-26 cm
2,7 cm
Right Thoracotomy-Enucleation
57
Dysphagia
Submucosal hypoechoic tumor at 27-33 cm
5,2 cm
Right Thoracotomy-Enucleation
61
Retrosternal burning, Dysphagia
Submucosal hypoechoic tumor at 20-27 cm
6,5 cm
Right Thoracotomy-Enucleation
55
Epigastric discomfort
Submucosal hypoechoic nodule at 29-34 cm
3,1 cm
Right Thoracotomy-Enucleation
EGS: Esophagogastroscopy, EUS: Endoscopic Ultrasonography

Discussion

Leiomyomas belong to benign mesenchymal tumors of esophagus. They are the most common non-malignant lesions of esophagus, with an incidence approaching 60% of all benign tumors of the organ [1]. The symptoms accompanying esophageal leiomyomas are not specific. It seems that the size of tumor correlates with the severity of the symptoms. Dysphagia with concomitant epigastric pain or retrosternal burning usually appears when the tumor's diameter becomes larger than the critical point of 4.5-5 cm [3]. Smaller leiomyomas may cause mild symptomatology, like unspecified discomfort, or even may be asymptomatic at all. In the majority of cases the lesions are located at the distal two thirds of the esophagus. In our small series, the distribution was almost equal in the two aforementioned positions.
Leiomyomas can mimic cancer of esophagus. Lack of specific symptoms as well as the similarity in initial clinical expression may cause diagnostic confusion. It is, therefore, obligatory the full preoperative investigation of each patient complaining for symptoms possibly relating with an esophageal lesion. Esophagogastroscopy combined with endoscopic ultrasonographic evaluation of the tumor is mandatory in order to exclude cancer of esophagus from the differential diagnosis [4, 5]. Leiomyoma's typical appearance is of homogeneous and hypoechoic lesion with clear margin (Fig 1, 2) [68]. Computed Tomography scans of the chest ideally complete the preoperative evaluation of the patients, revealing in most cases a mass originating from esophagus without mediastinal lymphadenopathy (Fig 3). Preoperative biopsy of the tumor is a debating issue [9]. Our policy is not to recommend it, because an esophageal leak or fistula can occur with a risk of potential mediastinitis. Moreover, in many cases fine needle aspiration could not provide enough material to establish an accurate histopathological diagnosis. The high risk of complications in combination with the small benefit for the patient suggests not to perform this diagnostic procedure, although other investigators recommend Fine Needle Biopsy via endoscopic ultrasonography.
Every symptomatic leiomyoma should be excised. In case the tumor is discovered accidentally, some authors recommend regular follow-up with barium swallow and endoscopy [9]. Our policy is that a surgical removal is recommended even in this situation, because there is always the possibility, rarely though, of malignant transformation.
Different kinds of approaches have been described depended from the location of the tumor. In the majority of the cases the tumor is discovered at the mean or the distal third of the esophagus. Right thoracotomy is suggested in first case; while a left thoracoabdominal approach fits better the second case [10]. Our experience shows that using a right postolateral thoracotomy, excision of the lesion is feasible in both locations. Myotomy of esophagus and extramucosal enucleation of the leiomyoma is the standard and established procedure. The external muscular layer of esophagus is incised longitudinally. Dissection and excision of the tumor with great care not to open the mucosa completes the surgical procedure. If mucosa is penetrated, careful reapproximation with absorbable sutures takes place, while closure of the muscle layers is obligatory, in order to prevent leak. A lung or pleural flap graft may be used in order to seal a potential leakage. In very few cases resection of part of esophagus is described for large tumors [2, 10]. In our opinion, enucleation of the tumor is the only indicated surgical approach of the leiomyoma. Esophagogastrectomy remains the operation of choice exclusively when dealing with esophageal cancer. It is a major operation with concomitant morbidity and mortality due to its possible severe complications.
Histopathologicaly, the tumor is composed of bland spindle cells and demonstrates low to moderate cellularity. The cells have eosinophilic and fibrillary cytoplasm (Fig 4). Mitotic figures are rare. Spherical calcifications are also focally present. Leiomyomas are presented typically globally positive for desmin and smooth muscle actin, while they are negative for CD34 and CD117 (c-kit) [11]. Differential diagnosis from esophageal cancer (squamous cell carcinoma of esophagus or adenocarcinoma of gastroesophageal junction) should not be a problem.

Conclusions

In conclusion, leiomyoma is a rare benign tumor of esophagus. Correct preoperative evaluation is of great importance in planning of the surgical excision. Enucleation of the lesion using a right postolateral thoracotomy is the most common approach. Postoperative complications are rare, while morbidity and mortality rates tend to be zero universally. Patients' relief from the symptoms is the rule and the prognosis is expected great.
Written informed consent was obtained from all patients for publication of this article and accompanying images. Copies of the written consents are available for review by the Editor-in-Chief of this journal.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​2.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

CA, DK, ML, AK, KS, and GZ took part in the care of the patients and contributed equally in carrying out the medical literature search and preparation of the manuscript. NB participated in the care of the patients and had the supervision of this report. All authors approved the final manuscript.
Anhänge

Authors’ original submitted files for images

Literatur
1.
Zurück zum Zitat Mutrie CJ, Donahue DM, Wain JC, Wright CD, Gaissert HA, Grillo HC, Mathisen DJ, Allan JS: Esophageal leiomyoma: a 40-year experience. Ann Thorac Surg. 2005, 79: 1122-5. 10.1016/j.athoracsur.2004.08.029.CrossRefPubMed Mutrie CJ, Donahue DM, Wain JC, Wright CD, Gaissert HA, Grillo HC, Mathisen DJ, Allan JS: Esophageal leiomyoma: a 40-year experience. Ann Thorac Surg. 2005, 79: 1122-5. 10.1016/j.athoracsur.2004.08.029.CrossRefPubMed
2.
Zurück zum Zitat Wang Y, Zhang R, Ouyang Z, Zhang D, Wang L, Zhang D: Diagnosis and surgical treatment of esophageal leiomyoma. Zhonghua Zhong Liu Za Zhi. 2002, 24: 394-6.PubMed Wang Y, Zhang R, Ouyang Z, Zhang D, Wang L, Zhang D: Diagnosis and surgical treatment of esophageal leiomyoma. Zhonghua Zhong Liu Za Zhi. 2002, 24: 394-6.PubMed
3.
Zurück zum Zitat Chak A: EUS in submucosal tumors. Gastrointest Endosc. 2002, 56 (Suppl 4): S43-48. 10.1016/S0016-5107(02)70085-0.CrossRefPubMed Chak A: EUS in submucosal tumors. Gastrointest Endosc. 2002, 56 (Suppl 4): S43-48. 10.1016/S0016-5107(02)70085-0.CrossRefPubMed
4.
Zurück zum Zitat Wang Y, Sun Y, Liu Y, Li Y, Wang Z: Transesophageal intraluminal ultrasonography in diagnosis and differential diagnosis of esophageal leiomyoma. Zhonghua Yixue Zazhi. 2002, 82: 456-458.PubMed Wang Y, Sun Y, Liu Y, Li Y, Wang Z: Transesophageal intraluminal ultrasonography in diagnosis and differential diagnosis of esophageal leiomyoma. Zhonghua Yixue Zazhi. 2002, 82: 456-458.PubMed
5.
Zurück zum Zitat Palazzo L, Landi B, Cellier C, Cuillerier E, Roseau G, Barbier JP: Endosonographic features predictive of benign and malignant gastrointestinal stromal cell tumours. Gut. 2000, 46: 88-92. 10.1136/gut.46.1.88.PubMedCentralCrossRefPubMed Palazzo L, Landi B, Cellier C, Cuillerier E, Roseau G, Barbier JP: Endosonographic features predictive of benign and malignant gastrointestinal stromal cell tumours. Gut. 2000, 46: 88-92. 10.1136/gut.46.1.88.PubMedCentralCrossRefPubMed
6.
Zurück zum Zitat Levine MS, Buck JL, Pantongrag-Brown L, Buetow PC, Lowry MA, Sobin LH: Esophageal leiomyomatosis. Radiology. 1996, 199: 533-36.CrossRefPubMed Levine MS, Buck JL, Pantongrag-Brown L, Buetow PC, Lowry MA, Sobin LH: Esophageal leiomyomatosis. Radiology. 1996, 199: 533-36.CrossRefPubMed
7.
Zurück zum Zitat Rosch T, Kapfer B, Will U, Baronius W, Strobel M, Lorenz R, Ulm K: Accuracy of endoscopic ultrasonography in upper gastrointestinal submucosal lesions: a prospective multicenter study. Scand J Gastroenterol. 2002, 37: 856-862.CrossRefPubMed Rosch T, Kapfer B, Will U, Baronius W, Strobel M, Lorenz R, Ulm K: Accuracy of endoscopic ultrasonography in upper gastrointestinal submucosal lesions: a prospective multicenter study. Scand J Gastroenterol. 2002, 37: 856-862.CrossRefPubMed
8.
Zurück zum Zitat Waxman I, Saitoh Y, Raju GS, Watari J, Yokota K, Reeves AL, Kohgo Y: High-frequency probe EUS-assisted endoscopic mucosal resection: a therapeutic strategy for submucosal tumors of the GI tract. Gastrointest Endosc. 2002, 55: 44-49. 10.1067/mge.2002.119871.CrossRefPubMed Waxman I, Saitoh Y, Raju GS, Watari J, Yokota K, Reeves AL, Kohgo Y: High-frequency probe EUS-assisted endoscopic mucosal resection: a therapeutic strategy for submucosal tumors of the GI tract. Gastrointest Endosc. 2002, 55: 44-49. 10.1067/mge.2002.119871.CrossRefPubMed
9.
Zurück zum Zitat Punpale A, Rangole A, Bhambhani N, Karimundackal G, Desai N, de Souza A, Pramesh CS, Jambhekar N, Mistry RC: Leiomyoma of Esophagus. Ann Thorac Cardiovasc Surg. 2007, 13: 78-81.PubMed Punpale A, Rangole A, Bhambhani N, Karimundackal G, Desai N, de Souza A, Pramesh CS, Jambhekar N, Mistry RC: Leiomyoma of Esophagus. Ann Thorac Cardiovasc Surg. 2007, 13: 78-81.PubMed
10.
Zurück zum Zitat Bonavina L, Segalin A, Rosati R, Pavanello M, Peracchia A: Surgical therapy of esophageal leiomyoma. J Am Coll Surg. 1995, 181: 257-62.PubMed Bonavina L, Segalin A, Rosati R, Pavanello M, Peracchia A: Surgical therapy of esophageal leiomyoma. J Am Coll Surg. 1995, 181: 257-62.PubMed
11.
Zurück zum Zitat Miettinen M, Lasota J: Gastrointestinal stromal tumors--definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch. 2001, 438: 1-12. 10.1007/s004280000338.CrossRefPubMed Miettinen M, Lasota J: Gastrointestinal stromal tumors--definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch. 2001, 438: 1-12. 10.1007/s004280000338.CrossRefPubMed
Metadaten
Titel
Nine years experience in surgical approach of leiomyomatosis of esophagus
verfasst von
Christos Asteriou
Dimitrios Konstantinou
Miltiadis Lalountas
Athanassios Kleontas
Konstantinos Setzis
Georgios Zafiriou
Nikolaos Barbetakis
Publikationsdatum
01.12.2009
Verlag
BioMed Central
Erschienen in
World Journal of Surgical Oncology / Ausgabe 1/2009
Elektronische ISSN: 1477-7819
DOI
https://doi.org/10.1186/1477-7819-7-102

Weitere Artikel der Ausgabe 1/2009

World Journal of Surgical Oncology 1/2009 Zur Ausgabe

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.